Featured Research

from universities, journals, and other organizations

NIH And Rockefeller Researchers Find That Gene Acts As "Caretaker" To Genome

Date:
April 24, 2000
Source:
Rockefeller University
Summary:
Researchers at the National Institutes of Health and Rockefeller University have found that a gene known for repairing breaks in the double strands of DNA also acts as a "caretaker" that prevents chromosome segments from rearranging. Recognizing this additional role for the gene, called Ku80, could increase ways of targeting some tumors that develop when the gene is mutated.

Researchers at the National Institutes of Health and Rockefeller University have found that a gene known for repairing breaks in the double strands of DNA also acts as a "caretaker" that prevents chromosome segments from rearranging. Recognizing this additional role for the gene, called Ku80, could increase ways of targeting some tumors that develop when the gene is mutated.

Related Articles


"We're learning that chromosomes are constantly breaking and being repaired by these caretaker genes," says co-author Michel Nussenzweig, M.D., Ph.D., Rockefeller professor and investigator with the Howard Hughes Medical Institute. "These genes are crucial for maintaining the integrity of the genome, and if the genes aren't working properly, it can lead to cancer down the road."

The research, reported in the March 30 issue of the journal Nature, was conducted at the National Institutes of Health and led by Andre Nussenzweig, Ph.D., a scientist in the Experimental Immunology Branch of the National Cancer Institute and brother of Michel Nussenzweig.

A number of genes in mammals have been linked to cancer because tumors are more likely to develop if the genes are mutated. In recent years, biologists have classified these "cancer-susceptibility genes" into two groups: "gatekeepers," which act as brakes on uncontrolled cell growth and division, and "caretakers," which keep the body's DNA from breaking or rearranging into the wrong sequence.

The most significant gatekeeper gene identified so far is p53, which was co-discovered by Rockefeller President Arnold J. Levine, Ph.D., in 1979. To protect the body from cancer, the p53 gene watches for cells that contain damaged DNA and either slows their growth until the DNA can be repaired or induces those cells to commit suicide. When a mutation occurs in p53, uncontrolled cell division that would be blocked in a person with a healthy copy of the gene often develops into cancer. Disruption of p53’s normal function is associated with an estimated 60 percent of human cancers.

Ku80 was already known to play an important role in repairing double-strand breaks in DNA, but it was not known until now that it has a caretaker role in preserving the stability of the genome. In the research reported in Nature, Nussenzweig and his colleagues showed that the cells of mice with a mutated Ku80 gene display a marked increase of chromosome breakage and jumbled sequence.

Despite these chromosomal instabilities, mice engineered to lack Ku80 develop cancer only slightly earlier than do normal mice, evidence that absence of Ku80 does not cause tumors directly. Instead, deficiency in Ku80 indirectly leads to tumors because it produces genetic changes that result in increased mutation of other genes, including p53. In this respect, Ku80 resembles the gene called BRCA1, which is well-known for its link to breast cancer.

Mice that are deficient in Ku80 and also have p53 mutations quickly develop tumors that are similar to those found in humans with a disease called Burkitt's lymphoma, in which tumors form in white cells in the blood and lymph glands.

The type of cell affected in Burkitt's lymphoma, the B lymphocyte, is normally involved in fighting infection by producing antibodies, the body’s defense against foreign intruders. The study suggests that Ku80 and p53 normally cooperate to prevent double-strand breaks in DNA from developing into tumors.

"While deficiency in p53 increases the risk of a broad range of cancers, deficiency in p53 and Ku80 is linked to more specific kinds of tumors," Nussenzweig says. "One hallmark of these tumors is that chromosome segments are out of order, suggesting that Ku80 normally functions to keep everything unbroken and in the right place."

In addition to Andre and Michel Nussenzweig, co-authors of the paper are Rockefeller postdoctoral associate Eric Meffre and Michael Difillppantinio, Jhe Zhu, Hua Tang Chen and Thomas Ried of the National Cancer Institute and Edward E. Max of the Food and Drug Administration. Funding was provided by the National Institutes of Health.

Rockefeller began in 1901 as The Rockefeller Institute for Medical Research, the first U.S. biomedical research center. Rockefeller faculty members have made significant achievements, including the discovery that DNA is the carrier of genetic information and the recent determination of the 3-D structure of the cellular RNA polymerase, a molecular machine that activates individual genes. The university has ties to 20 Nobel laureates, including the recipient of the 1999 Nobel Prize for Physiology or Medicine, Gόnter Blobel. Thirty-three faculty members are elected members of the U.S. National Academy of Sciences, including the president, Arnold J. Levine, Ph.D.


Story Source:

The above story is based on materials provided by Rockefeller University. Note: Materials may be edited for content and length.


Cite This Page:

Rockefeller University. "NIH And Rockefeller Researchers Find That Gene Acts As "Caretaker" To Genome." ScienceDaily. ScienceDaily, 24 April 2000. <www.sciencedaily.com/releases/2000/04/000424090918.htm>.
Rockefeller University. (2000, April 24). NIH And Rockefeller Researchers Find That Gene Acts As "Caretaker" To Genome. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2000/04/000424090918.htm
Rockefeller University. "NIH And Rockefeller Researchers Find That Gene Acts As "Caretaker" To Genome." ScienceDaily. www.sciencedaily.com/releases/2000/04/000424090918.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins